Report cover image

Diagnostics and Imaging Assistance Market By Type (X-ray, Magnetic Resonance Imaging (MRI) , Ultrasound, Computed Tomography (CT) , Others) , By End User (Hospitals and Clinics, Ambulatory Surgical Centers, Diagnostic Centers, Others) : Global Opportunity

Publisher Allied Market Research
Published Sep 01, 2024
Length 230 Pages
SKU # ALMR19510419

Description

Diagnostics and Imaging Assistance Market By Type (X-ray, Magnetic Resonance Imaging (MRI) , Ultrasound, Computed Tomography (CT) , Others) , By End User (Hospitals and Clinics, Ambulatory Surgical Centers, Diagnostic Centers, Others) : Global Opportunity Analysis and Industry Forecast, 2024-2033


Diagnostics and Imaging Assistance Market

The diagnostics and imaging assistance market was valued at $8.7 billion in 2023 and is projected to reach $14.9 billion by 2033, growing at a CAGR of 5.5% from 2024 to 2033.

Diagnostics and imaging assistance consists of tools and technologies designed to assist healthcare professionals in diagnosing body conditions and diseases. Different components of diagnostics & imaging assistance include X-ray, computed tomography, ultrasound, laboratory tests, and point-of-care testing. It is essential for the healthcare industry as it streamlines workflow through fast image analysis, enhances diagnostic accuracy, and improves patient outcomes through accurate examination. With advancements in technology & integration of AI algorithms, diagnostics and imaging assistance are anticipated to nurture a proactive approach in healthcare operations.

Increase in the prevalence of chronic diseases and rise in awareness regarding the importance of periodic health checkups are the key drivers of the diagnostics and imaging assistance market. In addition, upsurge in the popularity of early disease detection and administration of preventive care propels the development of the market. The integration of AI into diagnostics and imaging assistance is an emerging trend poised to transform the landscape of healthcare. AI-powered image analysis facilitates predictive & personalized care for each patient, thereby elevating the operational efficiency of diagnostic laboratories and medical facilities.

However, the high cost of procuring & maintaining advanced diagnostics and imaging equipment deters several small-scale facilities from investing in them, restraining the development of the market. Moreover, resistance to switching to ingenious tools & equipment owing to established workflows and training requirements hampers the market growth notably. On the contrary, the deployment of sensors and tele imaging techniques into the devices to support remote diagnostics is projected to present lucrative opportunities for the expansion of the diagnostics and imaging assistance market. According to Harvard Business Review, remote healthcare increases access to care by 20% and reduces healthcare expenditure by 15% to 20%. Therefore, the telehealth approach is anticipated to open new avenues for the market.

Segment Review

The diagnostics and imaging assistance market is segmented into type, end user, and region. On the basis of type, the market is divided into X-ray, magnetic resonance imaging (MRI), ultrasound, computed tomography (CT), and others. Depending on end user, it is classified into hospitals & clinics, ambulatory surgical centers, diagnostic centers, and others. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Key Findings

On the basis of type, the X-ray segment is projected to account for a high share of the market throughout the forecast period.

Depending on end user, the hospitals & clinics segment is expected to dominate the market share during the forecast period.

Region wise, North America is anticipated to be the highest revenue generator by 2033.

Competition Analysis

The major players of the global diagnostics and imaging assistance market include Canon Medical Systems Corporation, Subtle Medical, Inc., Samsung Healthcare, GE HealthCare, Digital Diagnostics Inc., Quibim, Lunit Inc., Aidence, NVIDIA Corporation, and Koninklijke Philips N.V. These major players have adopted various key development strategies such as business expansion, new product launches, and partnerships to strengthen their foothold in the competitive market.

Key Market Segments

By Type

X-ray
Magnetic Resonance Imaging (MRI)
Ultrasound
Computed Tomography (CT)
Others

By End User

Hospitals and Clinics
Ambulatory Surgical Centers
Diagnostic Centers
Others

By Region

North America
U.S.
Canada
Mexico
Europe
Germany
France
UK
Italy
Spain
Rest of Europe
Asia-Pacific
Japan
China
India
Australia
South Korea
Rest of Asia-Pacific
LAMEA
Brazil
Saudi Arabia
South Africa
Rest of LAMEA

Key Market Players

Canon Medical Systems Corporation
Subtle Medical, Inc.
Samsung Healthcare
GE HealthCare
Digital Diagnostics Inc.
Quibim
Lunit Inc.
Aidence
NVIDIA Corporation
Koninklijke Philips N.V.

Table of Contents

230 Pages
CHAPTER 1: INTRODUCTION
1.1. Report Description
1.2. Key Market Segments
1.3. Key Benefits
1.4. Research Methodology
1.4.1. Primary Research
1.4.2. Secondary Research
1.4.3. Analyst Tools and Models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. CXO Perspective
CHAPTER 3: MARKET LANDSCAPE
3.1. Market Definition and Scope
3.2. Key Findings
3.2.1. Top Investment Pockets
3.2.2. Top Winning Strategies
3.3. Porter's Five Forces Analysis
3.3.1. Bargaining Power of Suppliers
3.3.2. Threat of New Entrants
3.3.3. Threat of Substitutes
3.3.4. Competitive Rivalry
3.3.5. Bargaining Power among Buyers
3.4. Market Dynamics
3.4.1. Drivers
3.4.2. Restraints
3.4.3. Opportunities
CHAPTER 4: DIAGNOSTICS AND IMAGING ASSISTANCE MARKET, BY TYPE
4.1. Market Overview
4.1.1 Market Size and Forecast, By Type
4.2. X-ray
4.2.1. Key Market Trends, Growth Factors and Opportunities
4.2.2. Market Size and Forecast, By Region
4.2.3. Market Share Analysis, By Country
4.3. Magnetic Resonance Imaging (MRI)
4.3.1. Key Market Trends, Growth Factors and Opportunities
4.3.2. Market Size and Forecast, By Region
4.3.3. Market Share Analysis, By Country
4.4. Ultrasound
4.4.1. Key Market Trends, Growth Factors and Opportunities
4.4.2. Market Size and Forecast, By Region
4.4.3. Market Share Analysis, By Country
4.5. Computed Tomography (CT)
4.5.1. Key Market Trends, Growth Factors and Opportunities
4.5.2. Market Size and Forecast, By Region
4.5.3. Market Share Analysis, By Country
4.6. Others
4.6.1. Key Market Trends, Growth Factors and Opportunities
4.6.2. Market Size and Forecast, By Region
4.6.3. Market Share Analysis, By Country
CHAPTER 5: DIAGNOSTICS AND IMAGING ASSISTANCE MARKET, BY END USER
5.1. Market Overview
5.1.1 Market Size and Forecast, By End User
5.2. Hospitals And Clinics
5.2.1. Key Market Trends, Growth Factors and Opportunities
5.2.2. Market Size and Forecast, By Region
5.2.3. Market Share Analysis, By Country
5.3. Ambulatory Surgical Centers
5.3.1. Key Market Trends, Growth Factors and Opportunities
5.3.2. Market Size and Forecast, By Region
5.3.3. Market Share Analysis, By Country
5.4. Diagnostic Centers
5.4.1. Key Market Trends, Growth Factors and Opportunities
5.4.2. Market Size and Forecast, By Region
5.4.3. Market Share Analysis, By Country
5.5. Others
5.5.1. Key Market Trends, Growth Factors and Opportunities
5.5.2. Market Size and Forecast, By Region
5.5.3. Market Share Analysis, By Country
CHAPTER 6: DIAGNOSTICS AND IMAGING ASSISTANCE MARKET, BY REGION
6.1. Market Overview
6.1.1 Market Size and Forecast, By Region
6.2. North America
6.2.1. Key Market Trends and Opportunities
6.2.2. Market Size and Forecast, By Type
6.2.3. Market Size and Forecast, By End User
6.2.4. Market Size and Forecast, By Country
6.2.5. U.S. Diagnostics and Imaging Assistance Market
6.2.5.1. Market Size and Forecast, By Type
6.2.5.2. Market Size and Forecast, By End User
6.2.6. Canada Diagnostics and Imaging Assistance Market
6.2.6.1. Market Size and Forecast, By Type
6.2.6.2. Market Size and Forecast, By End User
6.2.7. Mexico Diagnostics and Imaging Assistance Market
6.2.7.1. Market Size and Forecast, By Type
6.2.7.2. Market Size and Forecast, By End User
6.3. Europe
6.3.1. Key Market Trends and Opportunities
6.3.2. Market Size and Forecast, By Type
6.3.3. Market Size and Forecast, By End User
6.3.4. Market Size and Forecast, By Country
6.3.5. Germany Diagnostics and Imaging Assistance Market
6.3.5.1. Market Size and Forecast, By Type
6.3.5.2. Market Size and Forecast, By End User
6.3.6. France Diagnostics and Imaging Assistance Market
6.3.6.1. Market Size and Forecast, By Type
6.3.6.2. Market Size and Forecast, By End User
6.3.7. UK Diagnostics and Imaging Assistance Market
6.3.7.1. Market Size and Forecast, By Type
6.3.7.2. Market Size and Forecast, By End User
6.3.8. Italy Diagnostics and Imaging Assistance Market
6.3.8.1. Market Size and Forecast, By Type
6.3.8.2. Market Size and Forecast, By End User
6.3.9. Spain Diagnostics and Imaging Assistance Market
6.3.9.1. Market Size and Forecast, By Type
6.3.9.2. Market Size and Forecast, By End User
6.3.10. Rest Of Europe Diagnostics and Imaging Assistance Market
6.3.10.1. Market Size and Forecast, By Type
6.3.10.2. Market Size and Forecast, By End User
6.4. Asia-Pacific
6.4.1. Key Market Trends and Opportunities
6.4.2. Market Size and Forecast, By Type
6.4.3. Market Size and Forecast, By End User
6.4.4. Market Size and Forecast, By Country
6.4.5. Japan Diagnostics and Imaging Assistance Market
6.4.5.1. Market Size and Forecast, By Type
6.4.5.2. Market Size and Forecast, By End User
6.4.6. China Diagnostics and Imaging Assistance Market
6.4.6.1. Market Size and Forecast, By Type
6.4.6.2. Market Size and Forecast, By End User
6.4.7. India Diagnostics and Imaging Assistance Market
6.4.7.1. Market Size and Forecast, By Type
6.4.7.2. Market Size and Forecast, By End User
6.4.8. Australia Diagnostics and Imaging Assistance Market
6.4.8.1. Market Size and Forecast, By Type
6.4.8.2. Market Size and Forecast, By End User
6.4.9. South Korea Diagnostics and Imaging Assistance Market
6.4.9.1. Market Size and Forecast, By Type
6.4.9.2. Market Size and Forecast, By End User
6.4.10. Rest of Asia-Pacific Diagnostics and Imaging Assistance Market
6.4.10.1. Market Size and Forecast, By Type
6.4.10.2. Market Size and Forecast, By End User
6.5. LAMEA
6.5.1. Key Market Trends and Opportunities
6.5.2. Market Size and Forecast, By Type
6.5.3. Market Size and Forecast, By End User
6.5.4. Market Size and Forecast, By Country
6.5.5. Brazil Diagnostics and Imaging Assistance Market
6.5.5.1. Market Size and Forecast, By Type
6.5.5.2. Market Size and Forecast, By End User
6.5.6. Saudi Arabia Diagnostics and Imaging Assistance Market
6.5.6.1. Market Size and Forecast, By Type
6.5.6.2. Market Size and Forecast, By End User
6.5.7. South Africa Diagnostics and Imaging Assistance Market
6.5.7.1. Market Size and Forecast, By Type
6.5.7.2. Market Size and Forecast, By End User
6.5.8. Rest of LAMEA Diagnostics and Imaging Assistance Market
6.5.8.1. Market Size and Forecast, By Type
6.5.8.2. Market Size and Forecast, By End User
CHAPTER 7: COMPETITIVE LANDSCAPE
7.1. Introduction
7.2. Top Winning Strategies
7.3. Product Mapping Of Top 10 Player
7.4. Competitive Dashboard
7.5. Competitive Heatmap
7.6. Top Player Positioning, 2023
CHAPTER 8: COMPANY PROFILES
8.1. Canon Medical Systems Corporation
8.1.1. Company Overview
8.1.2. Key Executives
8.1.3. Company Snapshot
8.1.4. Operating Business Segments
8.1.5. Product Portfolio
8.1.6. Business Performance
8.1.7. Key Strategic Moves and Developments
8.2. Subtle Medical, Inc. 
8.2.1. Company Overview
8.2.2. Key Executives
8.2.3. Company Snapshot
8.2.4. Operating Business Segments
8.2.5. Product Portfolio
8.2.6. Business Performance
8.2.7. Key Strategic Moves and Developments
8.3. Samsung Healthcare
8.3.1. Company Overview
8.3.2. Key Executives
8.3.3. Company Snapshot
8.3.4. Operating Business Segments
8.3.5. Product Portfolio
8.3.6. Business Performance
8.3.7. Key Strategic Moves and Developments
8.4. GE HealthCare
8.4.1. Company Overview
8.4.2. Key Executives
8.4.3. Company Snapshot
8.4.4. Operating Business Segments
8.4.5. Product Portfolio
8.4.6. Business Performance
8.4.7. Key Strategic Moves and Developments
8.5. Digital Diagnostics Inc.
8.5.1. Company Overview
8.5.2. Key Executives
8.5.3. Company Snapshot
8.5.4. Operating Business Segments
8.5.5. Product Portfolio
8.5.6. Business Performance
8.5.7. Key Strategic Moves and Developments
8.6. Quibim
8.6.1. Company Overview
8.6.2. Key Executives
8.6.3. Company Snapshot
8.6.4. Operating Business Segments
8.6.5. Product Portfolio
8.6.6. Business Performance
8.6.7. Key Strategic Moves and Developments
8.7. Lunit Inc.
8.7.1. Company Overview
8.7.2. Key Executives
8.7.3. Company Snapshot
8.7.4. Operating Business Segments
8.7.5. Product Portfolio
8.7.6. Business Performance
8.7.7. Key Strategic Moves and Developments
8.8. Aidence
8.8.1. Company Overview
8.8.2. Key Executives
8.8.3. Company Snapshot
8.8.4. Operating Business Segments
8.8.5. Product Portfolio
8.8.6. Business Performance
8.8.7. Key Strategic Moves and Developments
8.9.  NVIDIA Corporation
8.9.1. Company Overview
8.9.2. Key Executives
8.9.3. Company Snapshot
8.9.4. Operating Business Segments
8.9.5. Product Portfolio
8.9.6. Business Performance
8.9.7. Key Strategic Moves and Developments
8.10. Koninklijke Philips N.V.
8.10.1. Company Overview
8.10.2. Key Executives
8.10.3. Company Snapshot
8.10.4. Operating Business Segments
8.10.5. Product Portfolio
8.10.6. Business Performance
8.10.7. Key Strategic Moves and Developments
LIST OF TABLES
TABLE 1. GLOBAL DIAGNOSTICS AND IMAGING ASSISTANCE MARKET, BY TYPE, 2024 - 2033 ($BILLION)
TABLE 2. DIAGNOSTICS AND IMAGING ASSISTANCE MARKET FOR X-RAY, BY REGION, 2024 - 2033 ($BILLION)
TABLE 3. DIAGNOSTICS AND IMAGING ASSISTANCE MARKET FOR MAGNETIC RESONANCE IMAGING (MRI), BY REGION, 2024 - 2033 ($BILLION)
TABLE 4. DIAGNOSTICS AND IMAGING ASSISTANCE MARKET FOR ULTRASOUND, BY REGION, 2024 - 2033 ($BILLION)
TABLE 5. DIAGNOSTICS AND IMAGING ASSISTANCE MARKET FOR COMPUTED TOMOGRAPHY (CT), BY REGION, 2024 - 2033 ($BILLION)
TABLE 6. DIAGNOSTICS AND IMAGING ASSISTANCE MARKET FOR OTHERS, BY REGION, 2024 - 2033 ($BILLION)
TABLE 7. GLOBAL DIAGNOSTICS AND IMAGING ASSISTANCE MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 8. DIAGNOSTICS AND IMAGING ASSISTANCE MARKET FOR HOSPITALS AND CLINICS, BY REGION, 2024 - 2033 ($BILLION)
TABLE 9. DIAGNOSTICS AND IMAGING ASSISTANCE MARKET FOR AMBULATORY SURGICAL CENTERS, BY REGION, 2024 - 2033 ($BILLION)
TABLE 10. DIAGNOSTICS AND IMAGING ASSISTANCE MARKET FOR DIAGNOSTIC CENTERS, BY REGION, 2024 - 2033 ($BILLION)
TABLE 11. DIAGNOSTICS AND IMAGING ASSISTANCE MARKET FOR OTHERS, BY REGION, 2024 - 2033 ($BILLION)
TABLE 12. DIAGNOSTICS AND IMAGING ASSISTANCE MARKET, BY REGION, 2024 - 2033 ($BILLION)
TABLE 13. NORTH AMERICA DIAGNOSTICS AND IMAGING ASSISTANCE MARKET, BY COUNTRY, 2024 - 2033 ($BILLION)
TABLE 14. NORTH AMERICA DIAGNOSTICS AND IMAGING ASSISTANCE MARKET, BY TYPE, 2024 - 2033 ($BILLION)
TABLE 15. NORTH AMERICA DIAGNOSTICS AND IMAGING ASSISTANCE MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 16. U.S. DIAGNOSTICS AND IMAGING ASSISTANCE MARKET, BY TYPE, 2024 - 2033 ($BILLION)
TABLE 17. U.S. DIAGNOSTICS AND IMAGING ASSISTANCE MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 18. CANADA DIAGNOSTICS AND IMAGING ASSISTANCE MARKET, BY TYPE, 2024 - 2033 ($BILLION)
TABLE 19. CANADA DIAGNOSTICS AND IMAGING ASSISTANCE MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 20. MEXICO DIAGNOSTICS AND IMAGING ASSISTANCE MARKET, BY TYPE, 2024 - 2033 ($BILLION)
TABLE 21. MEXICO DIAGNOSTICS AND IMAGING ASSISTANCE MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 22. EUROPE DIAGNOSTICS AND IMAGING ASSISTANCE MARKET, BY COUNTRY, 2024 - 2033 ($BILLION)
TABLE 23. EUROPE DIAGNOSTICS AND IMAGING ASSISTANCE MARKET, BY TYPE, 2024 - 2033 ($BILLION)
TABLE 24. EUROPE DIAGNOSTICS AND IMAGING ASSISTANCE MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 25. GERMANY DIAGNOSTICS AND IMAGING ASSISTANCE MARKET, BY TYPE, 2024 - 2033 ($BILLION)
TABLE 26. GERMANY DIAGNOSTICS AND IMAGING ASSISTANCE MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 27. FRANCE DIAGNOSTICS AND IMAGING ASSISTANCE MARKET, BY TYPE, 2024 - 2033 ($BILLION)
TABLE 28. FRANCE DIAGNOSTICS AND IMAGING ASSISTANCE MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 29. UK DIAGNOSTICS AND IMAGING ASSISTANCE MARKET, BY TYPE, 2024 - 2033 ($BILLION)
TABLE 30. UK DIAGNOSTICS AND IMAGING ASSISTANCE MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 31. ITALY DIAGNOSTICS AND IMAGING ASSISTANCE MARKET, BY TYPE, 2024 - 2033 ($BILLION)
TABLE 32. ITALY DIAGNOSTICS AND IMAGING ASSISTANCE MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 33. SPAIN DIAGNOSTICS AND IMAGING ASSISTANCE MARKET, BY TYPE, 2024 - 2033 ($BILLION)
TABLE 34. SPAIN DIAGNOSTICS AND IMAGING ASSISTANCE MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 35. REST OF EUROPE DIAGNOSTICS AND IMAGING ASSISTANCE MARKET, BY TYPE, 2024 - 2033 ($BILLION)
TABLE 36. REST OF EUROPE DIAGNOSTICS AND IMAGING ASSISTANCE MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 37. ASIA-PACIFIC DIAGNOSTICS AND IMAGING ASSISTANCE MARKET, BY COUNTRY, 2024 - 2033 ($BILLION)
TABLE 38. ASIA-PACIFIC DIAGNOSTICS AND IMAGING ASSISTANCE MARKET, BY TYPE, 2024 - 2033 ($BILLION)
TABLE 39. ASIA-PACIFIC DIAGNOSTICS AND IMAGING ASSISTANCE MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 40. JAPAN DIAGNOSTICS AND IMAGING ASSISTANCE MARKET, BY TYPE, 2024 - 2033 ($BILLION)
TABLE 41. JAPAN DIAGNOSTICS AND IMAGING ASSISTANCE MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 42. CHINA DIAGNOSTICS AND IMAGING ASSISTANCE MARKET, BY TYPE, 2024 - 2033 ($BILLION)
TABLE 43. CHINA DIAGNOSTICS AND IMAGING ASSISTANCE MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 44. INDIA DIAGNOSTICS AND IMAGING ASSISTANCE MARKET, BY TYPE, 2024 - 2033 ($BILLION)
TABLE 45. INDIA DIAGNOSTICS AND IMAGING ASSISTANCE MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 46. AUSTRALIA DIAGNOSTICS AND IMAGING ASSISTANCE MARKET, BY TYPE, 2024 - 2033 ($BILLION)
TABLE 47. AUSTRALIA DIAGNOSTICS AND IMAGING ASSISTANCE MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 48. SOUTH KOREA DIAGNOSTICS AND IMAGING ASSISTANCE MARKET, BY TYPE, 2024 - 2033 ($BILLION)
TABLE 49. SOUTH KOREA DIAGNOSTICS AND IMAGING ASSISTANCE MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 50. REST OF ASIA-PACIFIC DIAGNOSTICS AND IMAGING ASSISTANCE MARKET, BY TYPE, 2024 - 2033 ($BILLION)
TABLE 51. REST OF ASIA-PACIFIC DIAGNOSTICS AND IMAGING ASSISTANCE MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 52. LAMEA DIAGNOSTICS AND IMAGING ASSISTANCE MARKET, BY COUNTRY, 2024 - 2033 ($BILLION)
TABLE 53. LAMEA DIAGNOSTICS AND IMAGING ASSISTANCE MARKET, BY TYPE, 2024 - 2033 ($BILLION)
TABLE 54. LAMEA DIAGNOSTICS AND IMAGING ASSISTANCE MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 55. BRAZIL DIAGNOSTICS AND IMAGING ASSISTANCE MARKET, BY TYPE, 2024 - 2033 ($BILLION)
TABLE 56. BRAZIL DIAGNOSTICS AND IMAGING ASSISTANCE MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 57. SAUDI ARABIA DIAGNOSTICS AND IMAGING ASSISTANCE MARKET, BY TYPE, 2024 - 2033 ($BILLION)
TABLE 58. SAUDI ARABIA DIAGNOSTICS AND IMAGING ASSISTANCE MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 59. SOUTH AFRICA DIAGNOSTICS AND IMAGING ASSISTANCE MARKET, BY TYPE, 2024 - 2033 ($BILLION)
TABLE 60. SOUTH AFRICA DIAGNOSTICS AND IMAGING ASSISTANCE MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 61. REST OF LAMEA DIAGNOSTICS AND IMAGING ASSISTANCE MARKET, BY TYPE, 2024 - 2033 ($BILLION)
TABLE 62. REST OF LAMEA DIAGNOSTICS AND IMAGING ASSISTANCE MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 63. CANON MEDICAL SYSTEMS CORPORATION: KEY EXECUTIVES
TABLE 64. CANON MEDICAL SYSTEMS CORPORATION: COMPANY SNAPSHOT
TABLE 65. CANON MEDICAL SYSTEMS CORPORATION: OPERATING SEGMENTS
TABLE 66. CANON MEDICAL SYSTEMS CORPORATION: PRODUCT PORTFOLIO
TABLE 67. CANON MEDICAL SYSTEMS CORPORATION: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 68. SUBTLE MEDICAL, INC. : KEY EXECUTIVES
TABLE 69. SUBTLE MEDICAL, INC. : COMPANY SNAPSHOT
TABLE 70. SUBTLE MEDICAL, INC. : OPERATING SEGMENTS
TABLE 71. SUBTLE MEDICAL, INC. : PRODUCT PORTFOLIO
TABLE 72. SUBTLE MEDICAL, INC. : KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 73. SAMSUNG HEALTHCARE: KEY EXECUTIVES
TABLE 74. SAMSUNG HEALTHCARE: COMPANY SNAPSHOT
TABLE 75. SAMSUNG HEALTHCARE: OPERATING SEGMENTS
TABLE 76. SAMSUNG HEALTHCARE: PRODUCT PORTFOLIO
TABLE 77. SAMSUNG HEALTHCARE: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 78. GE HEALTHCARE: KEY EXECUTIVES
TABLE 79. GE HEALTHCARE: COMPANY SNAPSHOT
TABLE 80. GE HEALTHCARE: OPERATING SEGMENTS
TABLE 81. GE HEALTHCARE: PRODUCT PORTFOLIO
TABLE 82. GE HEALTHCARE: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 83. DIGITAL DIAGNOSTICS INC.: KEY EXECUTIVES
TABLE 84. DIGITAL DIAGNOSTICS INC.: COMPANY SNAPSHOT
TABLE 85. DIGITAL DIAGNOSTICS INC.: OPERATING SEGMENTS
TABLE 86. DIGITAL DIAGNOSTICS INC.: PRODUCT PORTFOLIO
TABLE 87. DIGITAL DIAGNOSTICS INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 88. QUIBIM: KEY EXECUTIVES
TABLE 89. QUIBIM: COMPANY SNAPSHOT
TABLE 90. QUIBIM: OPERATING SEGMENTS
TABLE 91. QUIBIM: PRODUCT PORTFOLIO
TABLE 92. QUIBIM: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 93. LUNIT INC.: KEY EXECUTIVES
TABLE 94. LUNIT INC.: COMPANY SNAPSHOT
TABLE 95. LUNIT INC.: OPERATING SEGMENTS
TABLE 96. LUNIT INC.: PRODUCT PORTFOLIO
TABLE 97. LUNIT INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 98. AIDENCE: KEY EXECUTIVES
TABLE 99. AIDENCE: COMPANY SNAPSHOT
TABLE 100. AIDENCE: OPERATING SEGMENTS
TABLE 101. AIDENCE: PRODUCT PORTFOLIO
TABLE 102. AIDENCE: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 103.  NVIDIA CORPORATION: KEY EXECUTIVES
TABLE 104.  NVIDIA CORPORATION: COMPANY SNAPSHOT
TABLE 105.  NVIDIA CORPORATION: OPERATING SEGMENTS
TABLE 106.  NVIDIA CORPORATION: PRODUCT PORTFOLIO
TABLE 107.  NVIDIA CORPORATION: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 108. KONINKLIJKE PHILIPS N.V.: KEY EXECUTIVES
TABLE 109. KONINKLIJKE PHILIPS N.V.: COMPANY SNAPSHOT
TABLE 110. KONINKLIJKE PHILIPS N.V.: OPERATING SEGMENTS
TABLE 111. KONINKLIJKE PHILIPS N.V.: PRODUCT PORTFOLIO
TABLE 112. KONINKLIJKE PHILIPS N.V.: KEY STRATEGIC MOVES AND DEVELOPMENTS
LIST OF FIGURES
FIGURE 1. GLOBAL DIAGNOSTICS AND IMAGING ASSISTANCE MARKET, 2024 - 2033
FIGURE 2. SEGMENTATION OF DIAGNOSTICS AND IMAGING ASSISTANCE MARKET, 2024 - 2033
FIGURE 3. TOP INVESTMENT POCKET IN DIAGNOSTICS AND IMAGING ASSISTANCE MARKET
FIGURE 4. MODERATE BARGAINING POWER OF BUYERS
FIGURE 5. MODERATE BARGAINING POWER OF SUPPLIERS
FIGURE 6. MODERATE THREAT OF NEW ENTRANTS
FIGURE 7. LOW THREAT OF SUBSTITUTION
FIGURE 8. HIGH COMPETITIVE RIVALRY
FIGURE 9. OPPORTUNITIES, RESTRAINTS AND DRIVERS: GLOBALDIAGNOSTICS AND IMAGING ASSISTANCE MARKET
FIGURE 10. GLOBAL DIAGNOSTICS AND IMAGING ASSISTANCE MARKET SEGMENTATION, BY TYPE
FIGURE 11. DIAGNOSTICS AND IMAGING ASSISTANCE MARKET FOR X-RAY, BY COUNTRY, 2024 - 2033 ($BILLION)
FIGURE 12. DIAGNOSTICS AND IMAGING ASSISTANCE MARKET FOR MAGNETIC RESONANCE IMAGING (MRI), BY COUNTRY, 2024 - 2033 ($BILLION)
FIGURE 13. DIAGNOSTICS AND IMAGING ASSISTANCE MARKET FOR ULTRASOUND, BY COUNTRY, 2024 - 2033 ($BILLION)
FIGURE 14. DIAGNOSTICS AND IMAGING ASSISTANCE MARKET FOR COMPUTED TOMOGRAPHY (CT), BY COUNTRY, 2024 - 2033 ($BILLION)
FIGURE 15. DIAGNOSTICS AND IMAGING ASSISTANCE MARKET FOR OTHERS, BY COUNTRY, 2024 - 2033 ($BILLION)
FIGURE 16. GLOBAL DIAGNOSTICS AND IMAGING ASSISTANCE MARKET SEGMENTATION, BY END USER
FIGURE 17. DIAGNOSTICS AND IMAGING ASSISTANCE MARKET FOR HOSPITALS AND CLINICS, BY COUNTRY, 2024 - 2033 ($BILLION)
FIGURE 18. DIAGNOSTICS AND IMAGING ASSISTANCE MARKET FOR AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2024 - 2033 ($BILLION)
FIGURE 19. DIAGNOSTICS AND IMAGING ASSISTANCE MARKET FOR DIAGNOSTIC CENTERS, BY COUNTRY, 2024 - 2033 ($BILLION)
FIGURE 20. DIAGNOSTICS AND IMAGING ASSISTANCE MARKET FOR OTHERS, BY COUNTRY, 2024 - 2033 ($BILLION)
FIGURE 21. TOP WINNING STRATEGIES, BY YEAR, 2021-2023*
FIGURE 22. TOP WINNING STRATEGIES, BY DEVELOPMENT, 2021-2023*
FIGURE 23. TOP WINNING STRATEGIES, BY COMPANY, 2021-2023*
FIGURE 24. PRODUCT MAPPING OF TOP 10 PLAYERS
FIGURE 25. COMPETITIVE DASHBOARD
FIGURE 26. COMPETITIVE HEATMAP: DIAGNOSTICS AND IMAGING ASSISTANCE MARKET
FIGURE 27. TOP PLAYER POSITIONING, 2023
FIGURE 28. CANON MEDICAL SYSTEMS CORPORATION: NET SALES, 2021-2023 ($BILLION)
FIGURE 29. CANON MEDICAL SYSTEMS CORPORATION: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 30. CANON MEDICAL SYSTEMS CORPORATION: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 31. SUBTLE MEDICAL, INC. : NET SALES, 2021-2023 ($BILLION)
FIGURE 32. SUBTLE MEDICAL, INC. : REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 33. SUBTLE MEDICAL, INC. : REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 34. SAMSUNG HEALTHCARE: NET SALES, 2021-2023 ($BILLION)
FIGURE 35. SAMSUNG HEALTHCARE: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 36. SAMSUNG HEALTHCARE: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 37. GE HEALTHCARE: NET SALES, 2021-2023 ($BILLION)
FIGURE 38. GE HEALTHCARE: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 39. GE HEALTHCARE: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 40. DIGITAL DIAGNOSTICS INC.: NET SALES, 2021-2023 ($BILLION)
FIGURE 41. DIGITAL DIAGNOSTICS INC.: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 42. DIGITAL DIAGNOSTICS INC.: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 43. QUIBIM: NET SALES, 2021-2023 ($BILLION)
FIGURE 44. QUIBIM: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 45. QUIBIM: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 46. LUNIT INC.: NET SALES, 2021-2023 ($BILLION)
FIGURE 47. LUNIT INC.: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 48. LUNIT INC.: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 49. AIDENCE: NET SALES, 2021-2023 ($BILLION)
FIGURE 50. AIDENCE: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 51. AIDENCE: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 52.  NVIDIA CORPORATION: NET SALES, 2021-2023 ($BILLION)
FIGURE 53.  NVIDIA CORPORATION: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 54.  NVIDIA CORPORATION: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 55. KONINKLIJKE PHILIPS N.V.: NET SALES, 2021-2023 ($BILLION)
FIGURE 56. KONINKLIJKE PHILIPS N.V.: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 57. KONINKLIJKE PHILIPS N.V.: REVENUE SHARE, BY REGION, 2023 (%)

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us